Key result
Drug-eluting stent use with abbreviated dual antiplatelet therapy is evaluated as a strategy after percutaneous coronary intervention for liver transplantation assessment.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Koshy et al. (2023) studied this question. Drug-eluting stent use with abbreviated dual antiplatelet therapy is evaluated as a strategy after percutaneous coronary intervention for liver transplantation assessment.
Synapse has enriched 10 related papers. Consider them for comparative context: